BetaShares Global Healthcare Currency Hedged ETF is a sector & thematic ETF from BetaShares — 66 holdings, with $163.0m under management. 98% of its money is in health care. Its two largest holdings, ELI LILLY & CO and JOHNSON & JOHNSON, make up 16% of the fund. It charges 0.57% a year.
Compare DRUG with another fund →About DRUG
- TypeSector & thematic
- IssuerBetaShares
- Size$163.0m
- Cost0.57% a year
- Holdings66
- Top sectorHealth Care 98%
- Top 2 holdings16%
Last month+1.1%
$8.83+1.15% price
DRUG rose 1.1% over the last month. On $10,000, that's +$115. NOVOB was the biggest drag at −$31; ABBV helped most at +$46.
1M high$9.00
1M low$8.68
Avg volume50k
Latest volume7k
Prices to 9 Oct closeNo distributions in this period
What moved it
Gain or loss per $10k invested
- ABBVAbbVie+$46
- LLYEli Lilly+$32
- NOVOBNovo Nordisk−$31
- TMOThermo Fisher+$30
- ISRGIntuitive+$30
- JNJJ&J−$29
- UNHUnitedHealth−$20
- Other 55 holdings−$2
- Other 53 holdings+$47
- UnattributedHedging, fees, timing+$15
- CompoundingDaily returns multiply, they do not add−$4
- Fund return+$115
- Other 2 kinds of news+$5
Each kind of news counts the days those moves happened; No flagged news is every other day. News is tracked for moves large enough to be flagged; most international holdings had none in this range.
All 66 holdings
HideCodeWeightContribution, 1M
Loading every holding…
Country
per $10k
- Other 4 countries−$22
- Other 2 countries−$4